Company news

Immunocore Holdings PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Immunocore announces first patient dosed in the Phase 1 trial of IMC-S118AI – its first tissue-specific autoimmune candidate – for patients with type 1 diabetes

October 15, 2026

Decks

The 5 newest of 14 decks. Every deck is listed under its year.